September 29, 2017 / 10:06 PM / 21 days ago

BRIEF-Immunoprecise Antibodies reports Q1 2018 results

Sept 29 (Reuters) - Immunoprecise Antibodies Ltd:

* Immunoprecise Antibodies reports Q1 2018 results

* For three months ended July 31, 2017 co incurred operating loss of $857,832 compared to profit of $148,939 last year Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below